Fiscal year 2025 executive and director compensation, incentive-plan design, equity activity, and governance — every figure in this brief is traceable to its exact location in the company’s SEC filing — the document, the section, the page, and the table, linked directly.
Each company listed discloses PRVA in its own benchmarking peer group, as disclosed in each company's most recent proxy statement within the last two proxy seasons. Two companies are therefore absent by design: one that named PRVA in an earlier year and no longer does, and one whose own most recent disclosure is older than the last two seasons.
| Named executive officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|
| Parth Mehrotra | $650,000 | $0 | $8,588,373 | $0 | $1,218,750 | $0 | $15,575 | $10,472,698 |
| Chief Executive Officer | ||||||||
| David Mountcastle | 390,000 | 0 | 2,147,067 | 0 | 468,000 | 0 | 15,575 | 3,020,642 |
| Executive Vice President & Chief Financial Officer | ||||||||
| Edward Fargis | 385,000 | 0 | 1,610,301 | 0 | 346,500 | 0 | 15,575 | 2,357,376 |
| Executive Vice President & General Counsel | ||||||||
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.
| Named executive officer | FY2025 total | FY2024 total | FY2023 total | Δ FY2024→2025 |
|---|---|---|---|---|
| Parth Mehrotra | $10,472,698 | — | — | — |
| David Mountcastle | 3,020,642 | — | — | — |
| Edward Fargis | 2,357,376 | — | — | — |
Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.
Every insider equity transaction reported on Form 4 after the 2025 proxy statement — acquisitions, dispositions, exercises, and withholdings — and therefore not reflected in any table in that document.
| Insider | Role | Transaction date | Code | Shares | Price | Value | Security | Source |
|---|---|---|---|---|---|---|---|---|
| David Mountcastle | EVP & Chief Financial Officer | 2026-04-02 | D | 5,566 | $21 | $116,051 | Common | Form 4 ↗ |
| Shawn Morris | Director | 2026-05-01 | A | 17,096 | 2 | 34,192 | Common | Form 4 ↗ |
| Dividend-equivalent accruals | 2026-05-01 | — | 4,061 | — | — | 2 insiders, 7 accrual rows | ||
| Shawn Morris | Director | 2026-05-01 | A | 1,017 | 2 | 2,034 | Common | Form 4 ↗ |
| Shawn Morris | Director | 2026-05-01 | D | 17,096 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| David Mountcastle | EVP & Chief Financial Officer | 2026-05-01 | D | 2,331 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| David Mountcastle | EVP & Chief Financial Officer | 2026-05-01 | D | 7,179 | 25 | 179,690 | Common | Form 4 ↗ |
| Shawn Morris | Director | 2026-05-01 | D | 1,017 | 25 | 25,384 | Common | Form 4 ↗ |
| Shawn Morris | Director | 2026-05-01 | D | 17,096 | 25 | 427,229 | Common | Form 4 ↗ |
| David Mountcastle | EVP & Chief Financial Officer | 2026-05-01 | A | 7,179 | 2 | 14,358 | Common | Form 4 ↗ |
| David Mountcastle | EVP & Chief Financial Officer | 2026-05-01 | A | 1,206 | 2 | 2,412 | Common | Form 4 ↗ |
| David Mountcastle | EVP & Chief Financial Officer | 2026-05-01 | D | 1,206 | 25 | 30,150 | Common | Form 4 ↗ |
| David Mountcastle | EVP & Chief Financial Officer | 2026-05-01 | D | 3,010 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Parth Mehrotra | Director | 2026-05-11 | D | 105,439 | 23 | 2,377,649 | Common | Form 4 ↗ |
| David Mountcastle | EVP & Chief Financial Officer | 2026-05-11 | D | 3,385 | 23 | 76,501 | Common | Form 4 ↗ |
| Parth Mehrotra | Director | 2026-05-11 | D | 15,647 | 23 | 354,248 | Common | Form 4 ↗ |
| David King | Director | 2026-05-20 | A | 8,463 | 0 | 0 | Common | Form 4 ↗ |
| Pamela Kimmet | Director | 2026-05-20 | A | 8,463 | 0 | 0 | Common | Form 4 ↗ |
| Shawn Morris | Director | 2026-05-20 | A | 8,463 | 0 | 0 | Common | Form 4 ↗ |
| Lance Berberian | Director | 2026-05-20 | A | 8,463 | 0 | 0 | Common | Form 4 ↗ |
| Francis S. Soistman Jr | Director | 2026-05-20 | A | 8,463 | 0 | 0 | Common | Form 4 ↗ |
| Nancy Cocozza | Director | 2026-05-20 | A | 8,463 | 0 | 0 | Common | Form 4 ↗ |
| Thomas McCarthy | Director | 2026-05-20 | A | 8,463 | 0 | 0 | Common | Form 4 ↗ |
| Jaewon Ryu | Director | 2026-05-20 | A | 8,463 | 0 | 0 | Common | Form 4 ↗ |
| David Mountcastle | EVP & Chief Financial Officer | 2026-06-26 | D | 8,897 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| David Mountcastle | EVP & Chief Financial Officer | 2026-06-26 | D | 17,196 | 25 | 432,995 | Common | Form 4 ↗ |
| David Mountcastle | EVP & Chief Financial Officer | 2026-06-26 | D | 5,962 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Shawn Morris | Director | 2026-06-26 | A | 63,212 | 2 | 126,424 | Common | Form 4 ↗ |
| Shawn Morris | Director | 2026-06-26 | D | 88,110 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Shawn Morris | Director | 2026-06-26 | D | 63,212 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| David Mountcastle | EVP & Chief Financial Officer | 2026-06-26 | A | 17,196 | 2 | 34,392 | Common | Form 4 ↗ |
| Dividend-equivalent accruals | 2026-06-26 | — | 2,337 | — | — | 1 insider, 2 accrual rows | ||
| Shawn Morris | Director | 2026-06-26 | A | 88,110 | 2 | 176,220 | Common | Form 4 ↗ |
| Shawn Morris | Director | 2026-06-26 | D | 88,110 | 25 | 2,231,826 | Common | Form 4 ↗ |
| Shawn Morris | Director | 2026-06-26 | D | 63,212 | 25 | 1,601,160 | Common | Form 4 ↗ |
| Shawn Morris | Director | 2026-06-30 | A | 82,675 | 2 | 165,350 | Common | Form 4 ↗ |
| Shawn Morris | Director | 2026-06-30 | D | 52,823 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Shawn Morris | Director | 2026-06-30 | A | 52,823 | 2 | 105,646 | Common | Form 4 ↗ |
| Shawn Morris | Director | 2026-06-30 | D | 45,634 | 27 | 1,210,214 | Common | Form 4 ↗ |
| Shawn Morris | Director | 2026-06-30 | D | 82,675 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Shawn Morris | Director | 2026-06-30 | D | 37,041 | 27 | 997,514 | Common | Form 4 ↗ |
| Shawn Morris | Director | 2026-06-30 | D | 52,823 | 26 | 1,358,608 | Common | Form 4 ↗ |
| Shawn Morris | Director | 2026-07-02 | A | 53,722 | 2 | 107,444 | Common | Form 4 ↗ |
| Shawn Morris | Director | 2026-07-02 | D | 59,037 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Shawn Morris | Director | 2026-07-02 | D | 59,037 | 27 | 1,613,481 | Common | Form 4 ↗ |
| Shawn Morris | Director | 2026-07-02 | D | 53,722 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Shawn Morris | Director | 2026-07-02 | A | 59,037 | 2 | 118,074 | Common | Form 4 ↗ |
| Shawn Morris | Director | 2026-07-02 | D | 53,722 | 27 | 1,463,387 | Common | Form 4 ↗ |
| David Mountcastle | EVP & Chief Financial Officer | 2026-07-02 | D | 24,734 | 28 | 680,185 | Common | Form 4 ↗ |
| David Mountcastle | EVP & Chief Financial Officer | 2026-07-07 | D | 600 | 28 | 16,542 | Common | Form 4 ↗ |
| David Mountcastle | EVP & Chief Financial Officer | 2026-07-09 | D | 21,275 | 28 | 588,679 | Common | Form 4 ↗ |
Transaction codes per Form 4: A acquisition · S open-market sale · F tax withholding · M option exercise · G gift. Value = shares × price as reported. Dividend-equivalent and fractional-share accrual rows (derivative Class A, under $10,000 and under 2,000 shares) are aggregated per date; every row appears in full below.
| Insider | Role | Transaction date | Code | Shares | Price | Value | Security | Source |
|---|---|---|---|---|---|---|---|---|
| David Mountcastle | EVP & Chief Financial Officer | 2026-04-02 | D | 5,566 | $21 | $116,051 | Common | Form 4 ↗ |
| Shawn Morris | Director | 2026-05-01 | A | 17,096 | 2 | 34,192 | Common | Form 4 ↗ |
| David Mountcastle | EVP & Chief Financial Officer | 2026-05-01 | D | 592 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Shawn Morris | Director | 2026-05-01 | A | 1,017 | 2 | 2,034 | Common | Form 4 ↗ |
| Shawn Morris | Director | 2026-05-01 | D | 17,096 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Shawn Morris | Director | 2026-05-01 | D | 1,017 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| David Mountcastle | EVP & Chief Financial Officer | 2026-05-01 | D | 2,331 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| David Mountcastle | EVP & Chief Financial Officer | 2026-05-01 | D | 52 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| David Mountcastle | EVP & Chief Financial Officer | 2026-05-01 | D | 7,179 | 25 | 179,690 | Common | Form 4 ↗ |
| Shawn Morris | Director | 2026-05-01 | D | 1,017 | 25 | 25,384 | Common | Form 4 ↗ |
| Shawn Morris | Director | 2026-05-01 | D | 17,096 | 25 | 427,229 | Common | Form 4 ↗ |
| David Mountcastle | EVP & Chief Financial Officer | 2026-05-01 | D | 360 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| David Mountcastle | EVP & Chief Financial Officer | 2026-05-01 | A | 7,179 | 2 | 14,358 | Common | Form 4 ↗ |
| David Mountcastle | EVP & Chief Financial Officer | 2026-05-01 | A | 1,206 | 2 | 2,412 | Common | Form 4 ↗ |
| David Mountcastle | EVP & Chief Financial Officer | 2026-05-01 | D | 1,297 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| David Mountcastle | EVP & Chief Financial Officer | 2026-05-01 | D | 541 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| David Mountcastle | EVP & Chief Financial Officer | 2026-05-01 | D | 1,206 | 25 | 30,150 | Common | Form 4 ↗ |
| David Mountcastle | EVP & Chief Financial Officer | 2026-05-01 | D | 3,010 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| David Mountcastle | EVP & Chief Financial Officer | 2026-05-01 | D | 202 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Parth Mehrotra | Director | 2026-05-11 | D | 105,439 | 23 | 2,377,649 | Common | Form 4 ↗ |
| David Mountcastle | EVP & Chief Financial Officer | 2026-05-11 | D | 3,385 | 23 | 76,501 | Common | Form 4 ↗ |
| Parth Mehrotra | Director | 2026-05-11 | D | 15,647 | 23 | 354,248 | Common | Form 4 ↗ |
| David King | Director | 2026-05-20 | A | 8,463 | 0 | 0 | Common | Form 4 ↗ |
| Pamela Kimmet | Director | 2026-05-20 | A | 8,463 | 0 | 0 | Common | Form 4 ↗ |
| Shawn Morris | Director | 2026-05-20 | A | 8,463 | 0 | 0 | Common | Form 4 ↗ |
| Lance Berberian | Director | 2026-05-20 | A | 8,463 | 0 | 0 | Common | Form 4 ↗ |
| Francis S. Soistman Jr | Director | 2026-05-20 | A | 8,463 | 0 | 0 | Common | Form 4 ↗ |
| Nancy Cocozza | Director | 2026-05-20 | A | 8,463 | 0 | 0 | Common | Form 4 ↗ |
| Thomas McCarthy | Director | 2026-05-20 | A | 8,463 | 0 | 0 | Common | Form 4 ↗ |
| Jaewon Ryu | Director | 2026-05-20 | A | 8,463 | 0 | 0 | Common | Form 4 ↗ |
| David Mountcastle | EVP & Chief Financial Officer | 2026-06-26 | D | 8,897 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| David Mountcastle | EVP & Chief Financial Officer | 2026-06-26 | D | 17,196 | 25 | 432,995 | Common | Form 4 ↗ |
| David Mountcastle | EVP & Chief Financial Officer | 2026-06-26 | D | 5,962 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Shawn Morris | Director | 2026-06-26 | A | 63,212 | 2 | 126,424 | Common | Form 4 ↗ |
| Shawn Morris | Director | 2026-06-26 | D | 88,110 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Shawn Morris | Director | 2026-06-26 | D | 63,212 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| David Mountcastle | EVP & Chief Financial Officer | 2026-06-26 | A | 17,196 | 2 | 34,392 | Common | Form 4 ↗ |
| David Mountcastle | EVP & Chief Financial Officer | 2026-06-26 | D | 1,001 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| David Mountcastle | EVP & Chief Financial Officer | 2026-06-26 | D | 1,336 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Shawn Morris | Director | 2026-06-26 | A | 88,110 | 2 | 176,220 | Common | Form 4 ↗ |
| Shawn Morris | Director | 2026-06-26 | D | 88,110 | 25 | 2,231,826 | Common | Form 4 ↗ |
| Shawn Morris | Director | 2026-06-26 | D | 63,212 | 25 | 1,601,160 | Common | Form 4 ↗ |
| Shawn Morris | Director | 2026-06-30 | A | 82,675 | 2 | 165,350 | Common | Form 4 ↗ |
| Shawn Morris | Director | 2026-06-30 | D | 52,823 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Shawn Morris | Director | 2026-06-30 | A | 52,823 | 2 | 105,646 | Common | Form 4 ↗ |
| Shawn Morris | Director | 2026-06-30 | D | 45,634 | 27 | 1,210,214 | Common | Form 4 ↗ |
| Shawn Morris | Director | 2026-06-30 | D | 82,675 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Shawn Morris | Director | 2026-06-30 | D | 37,041 | 27 | 997,514 | Common | Form 4 ↗ |
| Shawn Morris | Director | 2026-06-30 | D | 52,823 | 26 | 1,358,608 | Common | Form 4 ↗ |
| Shawn Morris | Director | 2026-07-02 | A | 53,722 | 2 | 107,444 | Common | Form 4 ↗ |
| Shawn Morris | Director | 2026-07-02 | D | 59,037 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Shawn Morris | Director | 2026-07-02 | D | 59,037 | 27 | 1,613,481 | Common | Form 4 ↗ |
| Shawn Morris | Director | 2026-07-02 | D | 53,722 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Shawn Morris | Director | 2026-07-02 | A | 59,037 | 2 | 118,074 | Common | Form 4 ↗ |
| Shawn Morris | Director | 2026-07-02 | D | 53,722 | 27 | 1,463,387 | Common | Form 4 ↗ |
| David Mountcastle | EVP & Chief Financial Officer | 2026-07-02 | D | 24,734 | 28 | 680,185 | Common | Form 4 ↗ |
| David Mountcastle | EVP & Chief Financial Officer | 2026-07-07 | D | 600 | 28 | 16,542 | Common | Form 4 ↗ |
| David Mountcastle | EVP & Chief Financial Officer | 2026-07-09 | D | 21,275 | 28 | 588,679 | Common | Form 4 ↗ |
| Executive | Award | Grant date | Threshold | Target | Granted | Maximum | Grant-date fair value |
|---|---|---|---|---|---|---|---|
| Parth Mehrotra | RSU | 2025-03-05 | — | — | 133,723 | — | $3,435,344 |
| Parth Mehrotra | PSU | 2025-03-05 | 100,293 | 200,585 | 200,585 | 401,170 | 5,153,029 |
| David Mountcastle | PSU | 2025-03-05 | 25,073 | 50,146 | 50,146 | 100,292 | 1,288,251 |
| David Mountcastle | RSU | 2025-03-05 | — | — | 33,430 | — | 858,817 |
| Edward Fargis | RSU | 2025-03-05 | — | — | 25,073 | — | 644,125 |
| Edward Fargis | PSU | 2025-03-05 | 18,805 | 37,609 | 37,609 | 75,218 | 966,175 |
| Named executive officer | Time-vested (RSU) | Performance-vested (PSU) | Options / SARs | % performance-vested |
|---|---|---|---|---|
| Parth Mehrotra | $3,435,344 | $5,153,029 | $0 | 60.0% |
| David Mountcastle | 858,817 | 1,288,251 | 0 | 60.0% |
| Edward Fargis | 644,125 | 966,175 | 0 | 60.0% |
% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.
| Executive | Award | Shares unvested | Exercise price | Market value unvested |
|---|---|---|---|---|
| Edward Fargis | PSU | 42,816 | — | $1,015,167 |
| Parth Mehrotra | PSU | 133,723 | — | 3,170,572 |
| David Mountcastle | PSU | 50,146 | — | 1,188,962 |
| Edward Fargis | PSU | 19,030 | — | 451,201 |
| Parth Mehrotra | PSU | 200,585 | — | 4,755,870 |
| Parth Mehrotra | PSU | 5,173 | — | 122,652 |
| Parth Mehrotra | PSU | 179,828 | — | 4,263,722 |
| David Mountcastle | PSU | 25,373 | — | 601,594 |
| Parth Mehrotra | PSU | 24,510 | — | 581,132 |
| David Mountcastle | RSU | 39,856 | — | 955,458 |
| Parth Mehrotra | PSU | 110,294 | — | 2,615,071 |
| Parth Mehrotra | PSU | 79,924 | — | 1,894,998 |
| David Mountcastle | PSU | 57,088 | — | 1,353,556 |
| Edward Fargis | PSU | 44,404 | — | 1,052,819 |
| Edward Fargis | PSU | 37,609 | — | 891,709 |
| David Mountcastle | PSU | 33,430 | — | 792,625 |
| David Mountcastle | PSU | 33,088 | — | 784,516 |
| Edward Fargis | PSU | 25,073 | — | 594,481 |
| Parth Mehrotra | PSU | 23,276 | — | 551,874 |
| David Mountcastle | PSU | 7,353 | — | 174,340 |
| David Mountcastle | Option | 16,221 | 26.73 | — |
| Parth Mehrotra | PSU | 232,765 | — | 5,518,858 |
| David Mountcastle | PSU | 12,209 | — | 289,475 |
In general, we strive to provide total compensation that meets the market median when executive officers are consistently meeting the full expectations of their role. Executive officers may be compensated above or below the targeted market position based on factors such as experience, performance, scope of position and the competitive demand for proven executive talent.
| CEO STI target (% of salary) | 125% |
|---|---|
| CEO LTI target (% of salary) | — |
| Independent consultant | Korn Ferry (through September 2025), WTW (starting September 2025) |
| Clawback policy | true |
| Anti-hedging | true |
| Anti-pledging | True |
| Meeting year | Meeting date | For | Against | Abstain | Support | Outcome |
|---|---|---|---|---|---|---|
| 2026 | 2026-05-20 | 103,956,500 | 1,813,934 | 105,446 | 98.29% | Passed |
| 2025 | 2025-05-21 | 105,145,830 | 1,431,629 | 41,566 | 98.66% | Passed |
| 2024 | 2024-05-22 | 96,616,303 | 26,663,618 | 4,660,430 | 78.37% | Passed |
Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year's compensation.
| Meeting year | Meeting date | Approval — company's computation |
|---|---|---|
| 2026 | 2026-05-20 | 98.29%a |
| 2025 | 2025-05-21 | 98.66%b |
| 2024 | 2024-05-22 | 78.37%c |
a. Approved under the standard stated in the filing — “Abstentions and broker non-votes will have no effect on the outcome of this proposal.”.
b. Approved under the standard stated in the filing — “Abstentions and broker non-votes will have no effect on the outcome of this proposal.”.
c. Approved under the standard stated in the filing — “Abstentions and broker non-votes will have no effect on the outcome of this proposal.”.
Approval percentages are the company's own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.
| Ratio (CEO : median employee) | 168 : 1 |
|---|---|
| CEO total compensation | $10,472,698 |
| Median employee compensation | $62,334 |
| Director | Cash fees | Stock awards | Option awards | Non-equity incentive | All other | Total |
|---|---|---|---|---|---|---|
| David KingIndependent · Board Chair · Compensation · Nominating and Corporate Governance (Chair) | $145,000 | $199,825 | $0 | $0 | $0 | $344,825 |
| Thomas McCarthyIndependent · Audit (Chair) | 100,000 | 199,825 | 0 | 0 | 0 | 299,825 |
| Pamela KimmetIndependent · Compensation (Chair) · Nominating and Corporate Governance | 95,000 | 199,825 | 0 | 0 | 0 | 294,825 |
| Patricia MarylandIndependent · Compliance · Departed during FY | 77,083 | 199,825 | 0 | 0 | 0 | 276,908 |
| Jaewon RyuIndependent · Compliance (Chair) | 76,458 | 199,825 | 0 | 0 | -80 | 276,203 |
| Nancy CocozzaIndependent · Audit · Nominating and Corporate Governance | 75,000 | 199,825 | 0 | 0 | 0 | 274,825 |
| David WichmannIndependent · Audit · Compensation · Not standing for re-election | 75,000 | 199,825 | 0 | 0 | 0 | 274,825 |
| Shawn MorrisNot independent · Compliance | 75,000 | 199,825 | 0 | 0 | 0 | 274,825 |
| Lance BerberianIndependent · Audit · Compliance · Newly elected | 15,625 | 158,268 | 0 | 0 | 0 | 173,893 |
| Parth MehrotraEmployee director | 0 | 0 | 0 | — | 0 | 0 |
| Annual cash retainer | $75,000 |
|---|---|
| Annual equity retainer | $199,825 |
| Per board meeting fee | — |
| Committee chair fees (audit / comp / nom-gov) | 25,000 / 20,000 / 15,000 |
| Stock ownership guideline | — |
| Component | FY2025 |
|---|---|
| Cash retainers and fees | $734,166 |
| Equity awards (grant-date value) | $1,756,868 |
| All other compensation | $-80 |
| Total cost of the board | $2,490,954 |
Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.
The compensation peer group as the company disclosed it in its own proxy — the reference set behind the percentile above.
Of the companies Privia Health Group names as compensation peers, which name it back in their own disclosed peer groups. A peer set the market reciprocates reads differently from one selected in a single direction.
Reciprocity shown where the peer's own current proxy has been read — each mark is cited in the register to that peer's filing. A dash means the peer's current proxy was read and names no reciprocal group including Privia Health Group.
Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company's own proxy statement.
| Rank | Company | FY | Chief executive | Salary | Stock awards | Option awards | Non-equity incentive | Total |
|---|---|---|---|---|---|---|---|---|
| 1 | Goodrx Holdings, Inc. | 2025 | Wendy Barnes | $825,000 | $10,921,182 | $9,000,000 | $0 | $23,367,483 |
| 2 | Astrana Health, Inc. | 2025 | Brandon Sim | 850,000 | 11,999,980 | 0 | 2,059,125 | 14,930,231 |
| 3 | Evolent Health, Inc. | 2025 | Seth Blackley | 867,068 | 12,699,086 | 0 | 0 | 14,240,154 |
| 4 | Premier, Inc. | 2024 | Michael Alkire | 1,095,876 | 8,500,039 | 0 | 1,800,150 | 11,806,381 |
| 5 | Alignment Healthcare, Inc. | 2025 | John Kao | 833,654 | 8,500,014 | 0 | 1,944,495 | 11,278,583 |
| 6 | Teladoc Health, Inc. | 2025 | Charles Divita, III | 800,000 | 9,699,996 | 0 | 584,000 | 11,202,996 |
| 7 | Privia Health Group | 2025 | Parth Mehrotra | 650,000 | 8,588,373 | 0 | 1,218,750 | 10,472,698 |
| 8 | Claritev Corporation (f/k/a Multiplan Corporation) | 2025 | Travis Dalton | 825,000 | 8,234,542 | 0 | 1,134,375 | 10,202,667 |
| 9 | Phreesia, Inc. | 2026 | Chaim Indig | 515,000 | 7,562,706 | 0 | 0 | 8,077,706 |
| 10 | Surgery Partners, Inc. | 2025 | J. Eric Evans | 1,050,000 | 5,000,000 | 0 | 0 | 6,083,862 |
| 11 | Agilon Health, Inc. | 2025 | Jeffrey Schwaneke | 625,000 | 2,950,003 | 1,750,000 | 271,875 | 5,610,878 |
| 12 | Health Catalyst, Inc. | 2025 | Daniel Burton | 525,000 | 3,444,040 | 0 | 0 | 3,991,159 |
| 13 | Accolade, Inc. | 2024 | Rajeev Singh | 500,000 | 3,320,097 | 0 | 0 | 3,823,597 |
| 14 | Oscar Health, Inc. | 2025 | Mark Bertolini | 619,178 | 0 | 0 | 169,036 | 1,149,308 |
| — | Lifestance Health Group, Inc. | — | — | — | — | — | — | not in coverage universe |
Each peer's compensation is from its most recently filed proxy; fiscal years differ by company. Each peer's figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.
| Company | Annual incentive payout | Long-term vehicle mix | PSU measures include TSR | Compensation consultant |
|---|---|---|---|---|
| Privia Health Group | 150% | PSU 60 · RSU 40 | No | Korn Ferry (through September 2025), WTW (starting September 2025) |
| Accolade, Inc. | not disclosed | PSU 50 · RSU 50 | No | FW Cook |
| Agilon Health, Inc. | 58% | RSU 50 · Options 50 | No | Semler Brossy |
| Alignment Healthcare, Inc. | 200% | RSU 50 · PSU 50 | No | FW Cook |
| Astrana Health, Inc. | 193.8% | PSU 67 · RSU 33 | No | Pearl Meyer |
| Claritev Corporation (f/k/a Multiplan Corporation) | 110% | Cash LTI 75 · RSU 25 | not disclosed | Korn Ferry |
| Evolent Health, Inc. | 75% | PSU 70 · RSU 30 | No | Exequity |
| Goodrx Holdings, Inc. | 60.46% | RSU 50 · Options 50 | not disclosed | Pay Governance |
| Health Catalyst, Inc. | 39% | RSU 50 · PSU 50 | Yes — TSR Achievement | Aon (Human Capital Solutions practice) |
| Lifestance Health Group, Inc. | not disclosed | not disclosed | not disclosed | not disclosed |
| Oscar Health, Inc. | 91.0% | PSU 50 · RSU 50 | Yes — Relative TSR | FW Cook |
| Phreesia, Inc. | 140.3% | PSU 50 · RSU 50 | Yes — Relative TSR | FW Cook, Inc. |
| Premier, Inc. | 109.1% | PSU 60 · RSU 40 | No | Mercer |
| Surgery Partners, Inc. | not disclosed | PSU 60 · Restricted Stock 40 | No | Frederic W. Cook & Co., Inc. (FW Cook) |
| Teladoc Health, Inc. | 73% | RSU 50 · PSU 50 | No | Aon |
Read from each company's Compensation Discussion and Analysis: annual incentive payout as a percentage of target, the disclosed long-term vehicle mix, whether performance-share measures include a total shareholder return component, and the retained compensation consultant. “Not disclosed” appears only where the company's filing does not state the item.
Each figure's location is given both for the eye (section · page · table · row · column) and for a script (table/row/column index and exact character span in the filed document). Any figure can be independently confirmed against the source.
| # | Supports | Document | Filed | Accession | Location in document |
|---|---|---|---|---|---|
| 1 | Section 01, Parth Mehrotra | DEF 14A | 2026-04-02 | 0001193125-26-138997 | Section “2025 Summary Compensation Table” · page 37. As printed: 10,472,698. Filing ↗machine: t166 · r3 · c39 · span 538905–538915 |
| 2 | Section 01, David Mountcastle | DEF 14A | 2026-04-02 | 0001193125-26-138997 | Section “2025 Summary Compensation Table” · page 37. As printed: 3,020,642. Filing ↗machine: span 546861–546870 |
| 3 | Section 01, Edward Fargis | DEF 14A | 2026-04-02 | 0001193125-26-138997 | Section “2025 Summary Compensation Table” · page 37. As printed: 2,357,376. Filing ↗machine: span 554919–554928 |
| 4 | Section 03, Parth Mehrotra RSU | DEF 14A | 2026-04-02 | 0001193125-26-138997 | Section “EXECUTIVE COMPENSATION TABLES &” · grants of plan-based awards table. Filing ↗machine: t173 · r4 · c44 · span 575929–575938 |
| 5 | Section 03, Parth Mehrotra PSU | DEF 14A | 2026-04-02 | 0001193125-26-138997 | Section “EXECUTIVE COMPENSATION TABLES &” · grants of plan-based awards table. Filing ↗machine: t173 · r5 · c44 · span 578411–578420 |
| 6 | Section 03, David Mountcastle PSU | DEF 14A | 2026-04-02 | 0001193125-26-138997 | Section “EXECUTIVE COMPENSATION TABLES &” · grants of plan-based awards table. Filing ↗machine: t173 · r8 · c44 · span 585962–585971 |
| 7 | Section 03, David Mountcastle RSU | DEF 14A | 2026-04-02 | 0001193125-26-138997 | Section “EXECUTIVE COMPENSATION TABLES &” · grants of plan-based awards table. Filing ↗machine: t173 · r7 · c44 · span 583509–583516 |
| 8 | Section 03, Edward Fargis RSU | DEF 14A | 2026-04-02 | 0001193125-26-138997 | Section “EXECUTIVE COMPENSATION TABLES &” · grants of plan-based awards table. Filing ↗machine: t173 · r10 · c44 · span 591064–591071 |
| 9 | Section 03, Edward Fargis PSU | DEF 14A | 2026-04-02 | 0001193125-26-138997 | Section “EXECUTIVE COMPENSATION TABLES &” · grants of plan-based awards table. Filing ↗machine: t173 · r11 · c44 · span 595130–595137 |
| 10 | Section 07, pay ratio | DEF 14A | 2026-04-02 | 0001193125-26-138997 | Section “CEO Pay Ratio”. As printed: 168 : 1. Filing ↗ |
| 11 | Section 08, David King | DEF 14A | 2026-04-02 | 0001193125-26-138997 | Section “Director Compensation”. As printed: 344,825. Filing ↗machine: t233 · r6 · c14 · span 905798–905805 |
| 12 | Section 08, Thomas McCarthy | DEF 14A | 2026-04-02 | 0001193125-26-138997 | Section “Director Compensation”. As printed: 299,825. Filing ↗machine: t233 · r8 · c14 · span 907800–907807 |
| 13 | Section 08, Pamela Kimmet | DEF 14A | 2026-04-02 | 0001193125-26-138997 | Section “Director Compensation”. As printed: 294,825. Filing ↗machine: t233 · r5 · c14 · span 904790–904797 |
| 14 | Section 08, Patricia Maryland | DEF 14A | 2026-04-02 | 0001193125-26-138997 | Section “Director Compensation”. As printed: 276,908. Filing ↗machine: t233 · r7 · c14 · span 906787–906794 |
| 15 | Section 08, Jaewon Ryu | DEF 14A | 2026-04-02 | 0001193125-26-138997 | Section “Director Compensation”. As printed: 276,203. Filing ↗machine: t233 · r10 · c14 · span 909792–909799 |
| 16 | Section 08, Nancy Cocozza | DEF 14A | 2026-04-02 | 0001193125-26-138997 | Section “Director Compensation”. As printed: 274,825. Filing ↗machine: t233 · r4 · c14 · span 903805–903812 |
| 17 | Section 08, David Wichmann | DEF 14A | 2026-04-02 | 0001193125-26-138997 | Section “Director Compensation”. As printed: 274,825. Filing ↗machine: t233 · r11 · c14 · span 911307–911314 |
| 18 | Section 08, Shawn Morris | DEF 14A | 2026-04-02 | 0001193125-26-138997 | Section “Director Compensation”. As printed: 274,825. Filing ↗machine: t233 · r9 · c14 · span 908784–908791 |
| 19 | Section 08, Lance Berberian | DEF 14A | 2026-04-02 | 0001193125-26-138997 | Section “Director Compensation”. As printed: 173,893. Filing ↗machine: t233 · r2 · c14 · span 901696–901703 |
| 20 | Section 08, Parth Mehrotra | DEF 14A | 2026-04-02 | 0001193125-26-138997 | Section “Director Compensation”. As printed: 0. Filing ↗ |
| 21 | Section 02, David Mountcastle 2026-04-02 | Form 4 | 2026-04-06 | 0001858396-26-000006 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 22 | Section 02, Shawn Morris 2026-05-01 | Form 4 | 2026-05-05 | 0001759655-26-000020 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 23 | Section 02, David Mountcastle 2026-05-01 | Form 4 | 2026-05-05 | 0001858396-26-000009 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 24 | Section 02, Shawn Morris 2026-05-01 | Form 4 | 2026-05-05 | 0001759655-26-000020 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 25 | Section 02, Shawn Morris 2026-05-01 | Form 4 | 2026-05-05 | 0001759655-26-000020 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 26 | Section 02, Shawn Morris 2026-05-01 | Form 4 | 2026-05-05 | 0001759655-26-000020 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 27 | Section 02, David Mountcastle 2026-05-01 | Form 4 | 2026-05-05 | 0001858396-26-000009 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 28 | Section 02, David Mountcastle 2026-05-01 | Form 4 | 2026-05-05 | 0001858396-26-000009 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 29 | Section 02, David Mountcastle 2026-05-01 | Form 4 | 2026-05-05 | 0001858396-26-000009 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 30 | Section 02, Shawn Morris 2026-05-01 | Form 4 | 2026-05-05 | 0001759655-26-000020 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 31 | Section 02, Shawn Morris 2026-05-01 | Form 4 | 2026-05-05 | 0001759655-26-000020 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 32 | Section 02, David Mountcastle 2026-05-01 | Form 4 | 2026-05-05 | 0001858396-26-000009 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 33 | Section 02, David Mountcastle 2026-05-01 | Form 4 | 2026-05-05 | 0001858396-26-000009 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 34 | Section 02, David Mountcastle 2026-05-01 | Form 4 | 2026-05-05 | 0001858396-26-000009 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 35 | Section 02, David Mountcastle 2026-05-01 | Form 4 | 2026-05-05 | 0001858396-26-000009 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 36 | Section 02, David Mountcastle 2026-05-01 | Form 4 | 2026-05-05 | 0001858396-26-000009 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 37 | Section 02, David Mountcastle 2026-05-01 | Form 4 | 2026-05-05 | 0001858396-26-000009 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 38 | Section 02, David Mountcastle 2026-05-01 | Form 4 | 2026-05-05 | 0001858396-26-000009 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 39 | Section 02, David Mountcastle 2026-05-01 | Form 4 | 2026-05-05 | 0001858396-26-000009 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 40 | Section 02, Parth Mehrotra 2026-05-11 | Form 4 | 2026-05-13 | 0001759655-26-000030 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 41 | Section 02, David Mountcastle 2026-05-11 | Form 4 | 2026-05-13 | 0001858396-26-000011 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 42 | Section 02, Parth Mehrotra 2026-05-11 | Form 4 | 2026-05-13 | 0001759655-26-000030 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 43 | Section 02, David King 2026-05-20 | Form 4 | 2026-05-22 | 0001759655-26-000037 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 44 | Section 02, Pamela Kimmet 2026-05-20 | Form 4 | 2026-05-22 | 0001759655-26-000041 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 45 | Section 02, Shawn Morris 2026-05-20 | Form 4 | 2026-05-22 | 0001759655-26-000039 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 46 | Section 02, Lance Berberian 2026-05-20 | Form 4 | 2026-05-22 | 0001759655-26-000043 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 47 | Section 02, Francis S. Soistman Jr 2026-05-20 | Form 4 | 2026-05-22 | 0001759655-26-000044 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 48 | Section 02, Nancy Cocozza 2026-05-20 | Form 4 | 2026-05-22 | 0001759655-26-000042 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 49 | Section 02, Thomas McCarthy 2026-05-20 | Form 4 | 2026-05-22 | 0001759655-26-000040 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 50 | Section 02, Jaewon Ryu 2026-05-20 | Form 4 | 2026-05-22 | 0001759655-26-000038 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 51 | Section 02, David Mountcastle 2026-06-26 | Form 4 | 2026-06-30 | 0001759655-26-000046 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 52 | Section 02, David Mountcastle 2026-06-26 | Form 4 | 2026-06-30 | 0001759655-26-000046 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 53 | Section 02, David Mountcastle 2026-06-26 | Form 4 | 2026-06-30 | 0001759655-26-000046 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 54 | Section 02, Shawn Morris 2026-06-26 | Form 4 | 2026-06-30 | 0001759655-26-000048 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 55 | Section 02, Shawn Morris 2026-06-26 | Form 4 | 2026-06-30 | 0001759655-26-000048 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 56 | Section 02, Shawn Morris 2026-06-26 | Form 4 | 2026-06-30 | 0001759655-26-000048 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 57 | Section 02, David Mountcastle 2026-06-26 | Form 4 | 2026-06-30 | 0001759655-26-000046 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 58 | Section 02, David Mountcastle 2026-06-26 | Form 4 | 2026-06-30 | 0001759655-26-000046 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 59 | Section 02, David Mountcastle 2026-06-26 | Form 4 | 2026-06-30 | 0001759655-26-000046 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 60 | Section 02, Shawn Morris 2026-06-26 | Form 4 | 2026-06-30 | 0001759655-26-000048 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 61 | Section 02, Shawn Morris 2026-06-26 | Form 4 | 2026-06-30 | 0001759655-26-000048 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 62 | Section 02, Shawn Morris 2026-06-26 | Form 4 | 2026-06-30 | 0001759655-26-000048 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 63 | Section 02, Shawn Morris 2026-06-30 | Form 4 | 2026-07-02 | 0001759655-26-000053 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 64 | Section 02, Shawn Morris 2026-06-30 | Form 4 | 2026-07-02 | 0001759655-26-000053 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 65 | Section 02, Shawn Morris 2026-06-30 | Form 4 | 2026-07-02 | 0001759655-26-000053 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 66 | Section 02, Shawn Morris 2026-06-30 | Form 4 | 2026-07-02 | 0001759655-26-000053 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 67 | Section 02, Shawn Morris 2026-06-30 | Form 4 | 2026-07-02 | 0001759655-26-000053 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 68 | Section 02, Shawn Morris 2026-06-30 | Form 4 | 2026-07-02 | 0001759655-26-000053 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 69 | Section 02, Shawn Morris 2026-06-30 | Form 4 | 2026-07-02 | 0001759655-26-000053 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 70 | Section 02, Shawn Morris 2026-07-02 | Form 4 | 2026-07-07 | 0001401958-26-000010 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 71 | Section 02, Shawn Morris 2026-07-02 | Form 4 | 2026-07-07 | 0001401958-26-000010 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 72 | Section 02, Shawn Morris 2026-07-02 | Form 4 | 2026-07-07 | 0001401958-26-000010 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 73 | Section 02, Shawn Morris 2026-07-02 | Form 4 | 2026-07-07 | 0001401958-26-000010 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 74 | Section 02, Shawn Morris 2026-07-02 | Form 4 | 2026-07-07 | 0001401958-26-000010 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 75 | Section 02, Shawn Morris 2026-07-02 | Form 4 | 2026-07-07 | 0001401958-26-000010 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 76 | Section 02, David Mountcastle 2026-07-02 | Form 4 | 2026-07-07 | 0001858396-26-000014 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 77 | Section 02, David Mountcastle 2026-07-07 | Form 4 | 2026-07-09 | 0001858396-26-000016 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 78 | Section 02, David Mountcastle 2026-07-09 | Form 4 | 2026-07-13 | 0001759655-26-000057 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 79 | Section 06, 2026 vote | Form 8-K | 2026-05-22 | 0001759655-26-000034 | Item 5.07 · say-on-pay result. As reported: 98.29% (votes for as printed: 103,956,500). Filing ↗ |
| 80 | Section 06, 2025 vote | Form 8-K | 2025-05-22 | 0001759655-25-000056 | Item 5.07 · say-on-pay result. As reported: 98.66% (votes for as printed: 105,145,830). Filing ↗ |
| 81 | Section 06, 2024 vote | Form 8-K | 2024-05-23 | 0001759655-24-000076 | Item 5.07 · say-on-pay result. As reported: 78.37% (votes for as printed: 96,616,303). Filing ↗ |
| 82 | Section 03b vehicle mix (computed) | Computed | — | computed | RSU / PSU / Options grant-date fair values summed per officer from the grants table; % performance-vested = PSU ÷ (RSU+PSU+Options).machine: formula: sums + PSU ratio |
| 83 | Section 09b board cost (computed) | Computed | — | computed | Cash 734,166 + equity 1,756,868 + all other -80 = 2,490,954, summed across the director compensation table rows.machine: formula: Σ = 2,490,954 |
| 84 | Goodrx Holdings, Inc., Section 10b CEO total | DEF 14A | 2026-04-29 | 0001809519-26-000091 | CEO total compensation as printed in Goodrx Holdings, Inc.'s own proxy. As printed: 23,367,483. Filing ↗machine: t109 · r2 · c16 · span 1286734–1286744 |
| 85 | Astrana Health, Inc., Section 10b CEO total | DEF 14A | 2026-04-17 | 0001104659-26-044536 | CEO total compensation as printed in Astrana Health, Inc.'s own proxy. As printed: 14,930,231. Filing ↗machine: span 525189–525199 |
| 86 | Evolent Health, Inc., Section 10b CEO total | DEF 14A | 2026-04-24 | 0001193125-26-177267 | CEO total compensation as printed in Evolent Health, Inc.'s own proxy. As printed: 14,240,154. Filing ↗machine: r3 · c20 · span 908544–908555 |
| 87 | Premier, Inc., Section 10b CEO total | DEF 14A | 2024-10-21 | 0001193125-24-240399 | CEO total compensation as printed in Premier, Inc.'s own proxy. As printed: 11,806,381. Filing ↗machine: span 1173351–1173361 |
| 88 | Alignment Healthcare, Inc., Section 10b CEO total | DEF 14A | 2026-04-24 | 0001628280-26-027058 | CEO total compensation as printed in Alignment Healthcare, Inc.'s own proxy. As printed: 11,278,583. Filing ↗machine: r2 · c21 · span 656828–656838 |
| 89 | Teladoc Health, Inc., Section 10b CEO total | DEF 14A | 2026-04-07 | 0001477449-26-000020 | CEO total compensation as printed in Teladoc Health, Inc.'s own proxy. As printed: 11,202,996. Filing ↗machine: t167 · r2 · c16 · span 1057476–1057486 |
| 90 | Privia Health Group (subject), Section 10b CEO total | DEF 14A | 2026-04-02 | 0001193125-26-138997 | CEO total compensation as printed in Privia Health Group's own proxy. As printed: 10,472,698. Filing ↗machine: t166 · r3 · c39 · span 538905–538915 |
| 91 | Claritev Corporation (f/k/a Multiplan Corporation), Section 10b CEO total | DEF 14A | 2026-03-20 | 0001793229-26-000027 | CEO total compensation as printed in Claritev Corporation (f/k/a Multiplan Corporation)'s own proxy. As printed: 10,202,667. Filing ↗machine: r3 · c30 · span 707237–707247 |
| 92 | Phreesia, Inc., Section 10b CEO total | DEF 14A | 2026-05-14 | 0001412408-26-000155 | CEO total compensation as printed in Phreesia, Inc.'s own proxy. As printed: 8,077,706. Filing ↗machine: span 634967–634976 |
| 93 | Surgery Partners, Inc., Section 10b CEO total | DEF 14A | 2026-04-23 | 0001638833-26-000039 | CEO total compensation as printed in Surgery Partners, Inc.'s own proxy. As printed: 6,083,862. Filing ↗machine: r2 · c24 · span 365862–365872 |
| 94 | Agilon Health, Inc., Section 10b CEO total | DEF 14A | 2026-04-22 | 0001628280-26-026544 | CEO total compensation as printed in Agilon Health, Inc.'s own proxy. As printed: 5,610,878. Filing ↗machine: r5 · c9 · span 1591317–1591326 |
| 95 | Health Catalyst, Inc., Section 10b CEO total | DEF 14A | 2026-06-03 | 0001636422-26-000075 | CEO total compensation as printed in Health Catalyst, Inc.'s own proxy. As printed: 3,991,159. Filing ↗machine: span 702084–702093 |
| 96 | Accolade, Inc., Section 10b CEO total | DEF 14A | 2024-06-21 | 0001481646-24-000029 | CEO total compensation as printed in Accolade, Inc.'s own proxy. As printed: 3,823,597. Filing ↗machine: r2 · c42 · span 399607–399616 |
| 97 | Oscar Health, Inc., Section 10b CEO total | DEF 14A | 2026-04-22 | 0001140361-26-016119 | CEO total compensation as printed in Oscar Health, Inc.'s own proxy. As printed: 1,149,308. Filing ↗machine: t173 · r2 · c25 · span 1052592–1052601 |
| 98 | Section 10a, Agilon Health, Inc. reciprocity | DEF 14A | — | 0001628280-26-026544 | Agilon Health, Inc. names Privia Health Group in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 99 | Section 10a, Teladoc Health, Inc. reciprocity | DEF 14A | — | 0001477449-26-000020 | Teladoc Health, Inc. names Privia Health Group in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 100 | Section 10a, Alignment Healthcare, Inc. reciprocity | DEF 14A | — | 0001628280-26-027058 | Alignment Healthcare, Inc. names Privia Health Group in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 101 | Section 10a, Claritev Corporation (f/k/a Multiplan Corporation) reciprocity | DEF 14A | — | 0001793229-26-000027 | Claritev Corporation (f/k/a Multiplan Corporation)'s most recent proxy was read; its disclosed peer group does not include Privia Health Group. Filing ↗ |
| 102 | Section 10a, Phreesia, Inc. reciprocity | DEF 14A | — | 0001412408-26-000155 | Phreesia, Inc. names Privia Health Group in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 103 | Section 10a, Oscar Health, Inc. reciprocity | DEF 14A | — | 0001140361-26-016119 | Oscar Health, Inc.'s most recent proxy was read; its disclosed peer group does not include Privia Health Group. Filing ↗ |
| 104 | Section 10a, Accolade, Inc. reciprocity | DEF 14A | — | 0001481646-24-000029 | Accolade, Inc.'s most recent proxy was read; its disclosed peer group does not include Privia Health Group. Filing ↗ |
| 105 | Section 10a, Goodrx Holdings, Inc. reciprocity | DEF 14A | — | 0001809519-26-000091 | Goodrx Holdings, Inc. names Privia Health Group in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 106 | Section 10a, Health Catalyst, Inc. reciprocity | DEF 14A | — | 0001636422-26-000075 | Health Catalyst, Inc.'s most recent proxy was read; its disclosed peer group does not include Privia Health Group. Filing ↗ |
| 107 | Section 10a, Premier, Inc. reciprocity | DEF 14A | — | 0001193125-24-240399 | Premier, Inc.'s most recent proxy was read; its disclosed peer group does not include Privia Health Group. Filing ↗ |
| 108 | Section 10a, Surgery Partners, Inc. reciprocity | DEF 14A | — | 0001638833-26-000039 | Surgery Partners, Inc.'s most recent proxy was read; its disclosed peer group does not include Privia Health Group. Filing ↗ |
| 109 | Section 10a, Evolent Health, Inc. reciprocity | DEF 14A | — | 0001193125-26-177267 | Evolent Health, Inc.'s most recent proxy was read; its disclosed peer group does not include Privia Health Group. Filing ↗ |